23.46

1.30% 0.30

Envista Holdings Corp (NVST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$23.16

Offen:

$23.31

24-Stunden-Volumen:

2.35M

Relative Volume:

0.84

Marktkapitalisierung:

$3.77B

Einnahmen:

$2.72B

Nettoeinkommen (Verlust:

$47.00M

KGV:

85.34

EPS:

0.2749

Netto-Cashflow:

$230.40M

1W Leistung:

-2.05%

1M Leistung:

-14.35%

6M Leistung:

-9.10%

1J Leistung:

+14.05%

1-Tages-Spanne:

$23.12

$23.73

1-Wochen-Bereich:

$22.82

$24.05

52-Wochen-Spanne:

$18.77

$30.42

Envista Holdings Corp Stock (NVST) Company Profile

Firmenname

Envista Holdings Corp

Sektor

Healthcare (1064)

Branche

Medical Instruments & Supplies (56)

Telefon

714-817-5418

Adresse

200 S. KRAEMER BLVD., BLDG. E, BREA, CA

Mitarbeiter

12,000

Twitter

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

NVST's Discussions on Twitter

Compare NVST vs ISRG, BDX, RMD, MDLN, ALC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NVST Envista Holdings Corp	23.46	3.85B	2.72B	47.00M	230.40M	0.2749
ISRG Intuitive Surgical Inc	391.95	143.14B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	176.80	50.07B	21.37B	1.41B	3.07B	3.9437
RMD Resmed Inc	218.89	32.02B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.61	30.44B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	63.76	31.16B	10.63B	819.00M	1.59B	1.6577

Envista Holdings Corp Stock (NVST) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Eingeleitet	Citigroup	Neutral
2026-02-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-12-09	Eingeleitet	Barclays	Overweight
2025-05-27	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-12-04	Eingeleitet	Mizuho	Underperform
2024-10-31	Hochstufung	Leerink Partners	Underperform → Market Perform
2024-10-08	Eingeleitet	Wells Fargo	Equal Weight
2024-08-08	Herabstufung	JP Morgan	Overweight → Neutral
2024-04-26	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-02-26	Eingeleitet	Leerink Partners	Underperform
2024-02-09	Herabstufung	Jefferies	Buy → Hold
2024-02-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-01-05	Eingeleitet	UBS	Neutral
2023-12-11	Herabstufung	Goldman	Buy → Sell
2023-11-16	Eingeleitet	Needham	Hold
2023-11-02	Herabstufung	Piper Sandler	Overweight → Neutral
2022-08-29	Hochstufung	Piper Sandler	Neutral → Overweight
2022-06-14	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-01-31	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-10-26	Hochstufung	BofA Securities	Neutral → Buy
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-01-08	Hochstufung	Credit Suisse	Neutral → Outperform
2020-06-16	Eingeleitet	Piper Sandler	Neutral
2019-12-17	Fortgesetzt	Evercore ISI	Outperform
2019-10-14	Eingeleitet	BofA/Merrill	Neutral
2019-10-14	Eingeleitet	Credit Suisse	Neutral
2019-10-14	Eingeleitet	Evercore ISI	Outperform
2019-10-14	Eingeleitet	Goldman	Buy
2019-10-14	Eingeleitet	JP Morgan	Overweight
2019-10-14	Eingeleitet	Jefferies	Buy
2019-10-14	Eingeleitet	Morgan Stanley	Equal-Weight
2019-10-14	Eingeleitet	Robert W. Baird	Outperform
2019-10-14	Eingeleitet	Stifel	Buy
2019-10-14	Eingeleitet	William Blair	Outperform

Alle ansehen

Envista Holdings Corp Aktie (NVST) Neueste Nachrichten

Oct 01, 2026

Why Envista Holdings (NVST) Is Back In The Spotlight - Simply Wall Street

Oct 01, 2026

Leaner Operations and Improving Dental Demand Position Envista Holdings Corp. (NVST) for Multi-Year Growth - Yahoo Finance

Oct 01, 2026

Envista Holdings Corporation (NVST) Stock Forecasts - Yahoo! Finance Canada

Oct 01, 2026

Sep 30, 2026

Dental Equipment & Technology Stocks Q2 Earnings Review: Envista (NYSE:NVST) Shines - Yahoo Finance

Sep 30, 2026

Sep 28, 2026

Envista Holdings Price Target Cut to $26.00/Share From $29.00 by BMO Capital - Moomoo

Sep 28, 2026

Envista Holdings Corporation (NVST) Stock Price, News, Quote & History - ca.finance.yahoo.com

Sep 23, 2026

Sep 22, 2026

A Look at Envista Holdings Corp (NVST) After 3.2% Gain -- GF Val - GuruFocus

Sep 22, 2026

Sep 21, 2026

Envista Holdings (NVST), Why Is Investor Attention Building Now? - Yahoo Finance

Sep 21, 2026

Major dental manufacturers report a mixed second quarter - Dental Tribune US

Sep 21, 2026

Best Value Stocks to Buy for September 21st - The Globe and Mail

Sep 21, 2026

Best Value Stocks to Buy for September 21st - Zacks Investment Research

Sep 21, 2026

Sep 18, 2026

Envista Stock Volatility Reflects Expectations, Not Negative News, UBS Says - marketscreener.com

Sep 18, 2026

UBS cuts Envista stock price target on valuation review By Investing.com - Investing.com Nigeria

Sep 18, 2026

NVST Maintained by UBS -- Price Target Lowered to $27.00 - GuruFocus

Sep 18, 2026

UBS cuts Envista stock price target on valuation review - Investing.com

Sep 18, 2026

Should Value Investors Buy Envista (NVST) Stock? - Yahoo Finance

Sep 18, 2026

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST) - Yahoo Finance

Sep 18, 2026

Stifel reiterates Buy on Envista stock, keeps $31 price target By Investing.com - Investing.com Nigeria

Sep 18, 2026

Stifel reiterates Buy on Envista stock, keeps $31 price target - Investing.com India

Sep 18, 2026

Sep 17, 2026

Envista Holdings Unveils Strategic Vision at 2026 Investor Day on September 17 - Kalkine Media

Sep 17, 2026

Envista to Host 2026 Investor Day Outlining Strategy and Long-Term Objectives - TradingView

Sep 17, 2026

Sep 16, 2026

Envista launches Kerr dental consumables in India amid broader Asian expansion - Dental Tribune US

Sep 16, 2026

Sep 15, 2026